Leveraging a team of world-class experts, Bioptimus is building the first universal AI foundation model that connects biology at its different scales – from molecules to cells, tissues, and whole organisms.
Jean-Philippe Vert · Président de SAS · decision-maker
David Cahané · Directeur Général · decision-maker
Careers mailbox is known
Sep 30
Hiring 1 new role, 5 closed in 14 days
Mar 12, 2025
Increased its share capital $43k · BODACC
Jan 14, 2025
Raised a round Venture round $41M · TechCrunch
Oct 22, 2024
Partnership Bioptimus and Proscia Collaborate to Accelerate AI Innovation in Scientific Research and Drug Development for Improved Patient Care · businesswire.com
2014
Founded
6 open
+1 this week
closes in 61 d market 31
Unique Blood Pumps Inspired By Nature. CorWave is a clinical-stage company with the mission to expand the use of cardiac assist devices to tackle heart failure.
Louis-Emmanuel Le Duc De Lillers · Directeur Général · decision-maker
Gerard Hascoet · Président du conseil d’administration · decision-maker
No careers mailbox known
May 29
Certified CorWave Achieves Major Regulatory Milestone with ISO 13485 Certification Across its Entire Operations · morningstar.com
Apr 2, 2025
New executive CorWave Announces the Appointment of Dawn Sadlowski-Buisserez as Vice President of Operations to Support the Ramp-Up of Production · FinanzNachrichten.de
Jun 19, 2023
Raised a round Series C $65.9M
Dec 1, 2011
Founded per the company register
Latent Labs builds generative models that design proteins from a natural language description of the desired function. Founded in 2023 by a former DeepMind AlphaFold researcher, it released a web-based protein design model for scientists. The company aims to make biology programmable in the way software is.
No named decision-maker yet.
Careers mailbox is known
Jul 15
Launched Latent Labs Launches Latent-Y to Researchers Worldwide - With Free Daily Access and On-Demand Credits for Larger Campaigns · YahooFinance
Feb 12, 2025
Raised a round Venture round $50M
Jun 27, 2023
Founded per the company register
7 open
truth B 75 100% stale
Pincelli is a pre-clinical stage biotech company focused on the development of innovative first-in-class treatments for rare skin diseases.
No named decision-maker yet.
No careers mailbox known
News May 21, 2024 Inspirna Announces Appointment of Karim Benhadji, M.D., as Chief Medical Officer and Retirement of Robert Wasserman, M.D.
Saeed Tavazoie · Executive Officer, Director · decision-maker
David Darst · Executive Officer · decision-maker
Masoud Tavazoie · Executive Officer, Director · decision-maker
Eric Rowinsky · Director · decision-maker
Careers mailbox is known
May 21, 2024
New executive Inspirna Announces Appointment of Karim Benhadji, M.D., as Chief Medical Officer and Retirement of Robert Wasserman, M.D. · inspirna.com
Jan 3, 2024
Partnership Inspirna Partners with Merck KGaA, Darmstadt, Germany, to Accelerate Global Development of Ompenaclid (RGX-202) · businesswire.com
Jun 24, 2022
Raised a round Venture round $55.1M · SEC Form D
Driving immune-mediated therapeutic innovation for women. Freya focuses on the underlying drivers of disease, not just symptoms.
No named decision-maker yet.
Careers mailbox is known
About Excelsior We're Rebuilding the World from the Bottom Up: What Molecular Solution Are You Seeking? Excelsior Sciences is leveraging a new form of chemistry that machines can do, AI can learn from, and anyone can engage.
No named decision-maker yet.
No careers mailbox known
Elevara Medicines is a clinical-stage biotech. ELV001 targets fibroblast-like synoviocytes and synergizes with DMARDs to achieve clinical remission in RA.
No named decision-maker yet.
Careers mailbox is known
CorVent Medical provides simple, safe and smart respiratory solutions for healthcare professionals - RESPOND® ventilator and CorVision™.
Jeremy Nelson · Executive Officer · decision-maker
Travis Murphy · Executive Officer · decision-maker
Richard Walsh · Executive Officer, Director · decision-maker
John O'Mahony · Executive Officer · decision-maker
Careers mailbox is known
2025
Team shrank to 26 was 36 · US Form 5500 (plan participants)
Oct 22, 2025
Launched CorVent Medical Launches AI/ML-Driven CorVision SaaS Platform and Opens Series B Financing · YahooFinance
Apr 28, 2020
Raised a round Seed $4.5M · SEC Form D
2020
Founded
Alia Therapeutics is a startup which is developing next-generation gene editing medicines to cure genetic diseases.
No named decision-maker yet.
No careers mailbox known
Jan 1, 2024
Won a grant $156k · CORDIS
BiovelocITA: il primo acceleratore biotech in Italia.
No named decision-maker yet.
Careers mailbox is known
First purpose-built, minimally invasive, ultrasound-based system designed to treat patients with pulmonary hypertension due to left-sided heart disease.
No named decision-maker yet.
Careers mailbox is known
Galvanize Therapeutics designs pulsed electric field energy devices for the surgical ablation of soft tissue, engineered to work with the body's biology.
No named decision-maker yet.
Careers mailbox is known
Sep 30
Closed a role Research Scientist
Sep 28
Senior Service Engineer crossed 90 days open
Sep 25
Posted 9 roles Sr. Manager FP&A, Commercial & Operations, Sr. FP&A Manager, Corporate Finance
8 open
$173k stated pay, 6 roles
Hemab is pioneering the first preventative treatments and functional cures for patients with rare bleeding and thrombotic disorders.
No named decision-maker yet.
No careers mailbox known
Oct 27, 2025
Raised a round Venture round $157M · YahooFinance
BioCorteX runs in-silico bridge trials that map how the microbiome changes a drug.
No named decision-maker yet.
Careers mailbox is known
Mar 27, 2023
Raised a round Venture round $5M · led by Sofinnova Partners · FinanzNachrichten.de
Bionyra Pharma is a clinical-stage biopharmaceutical company developing next-generation biologics for severe immune-mediated inflammatory diseases. Bionyra’s.
No named decision-maker yet.
Careers mailbox is known
Aug 23
Increased its share capital $96k · BODACC
Mainstay Medical is improving quality of life for patients with chronic low back pain through innovative restorative treatment medical device solutions.
Jason Hannon · Director, Executive Officer · decision-maker
Matt Onaitis · Executive Officer · decision-maker
Cedric Moreau · Director
Charles Chon · Director
Careers mailbox is known
Sep 26
Posted 6 roles Therapy Specialist (Sales Associate), Therapy Specialist (Sales Associate)
Sep 25
Therapy Specialist (Sales Associate) crossed 45 days open
Feb 28, 2024
Raised a round Venture round $125M · Pulse 2.0
6 open
$145k stated pay, 6 roles
With ProZERO™ Supplemental Blend, we can reduce concrete’s carbon impact—to negative.
Loren Burnett · Executive Officer, Director · decision-maker
Vishaan Chakrabarti · Director
Josko Bobanovic · Director
Careers mailbox is known
Mar 28, 2022
Raised a round Venture round $4.1M · SEC Form D
2021
Founded
ProQR is a biotech company that discovers and develops unique RNA therapies for severe rare and common diseases, based in Leiden, The Netherlands.
No named decision-maker yet.
Careers mailbox is known
Sep 26
Moved to Teamtailor
Sep 23
New executive ProQR Announces Appointment of Chris Hart as Chief Data and AI Officer and Thomas Wolf to join the Board of Directors as Strategic AI Advisor · markets.businessinsider.com
On this page Key figures Home > Who we are > Company Our mission is to turn scientific advances in gene therapy into novel treatments for patients with severe degenerative diseases of the eye and the central nervous system.
No named decision-maker yet.
Careers mailbox is known
Mar 10
Raised a round Venture round $1.8M · Pulse 2.0
